Encompass Health Corp (EHC) stock
EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3013% above fair value
$140.83−1.41 (-0.99%)
Close on Nov 12, 2026Market cap $13.89BP/E 22.9Yield 0.51%
Encompass Health statistics
104 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 4, 2027 (estimated, during market hours)
- Last ex-dividend date
- Oct 1, 2026
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 14.36
- 5.80
- P/OCF Ratio
- 11.46
- 14.68
Enterprise valuationIndustry
- EV / Sales
- 2.78
- 1.67
- EV / FCF
- 41.67
- 24.49
Share statisticsIndustry
- Shares Change (YoY)
- -0.95%
- 2.40%
- Float
- 98M
- 34M
- Shares Held by Insiders
- 1.02%
- 15.4%
- Shares Held by Institutions
- 97.0%
- 83.6%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 9.10%
- -0.86%
- Short % of Float
- 3.70%
- 6.28%
- Short % of Shares Outstanding
- 3.66%
- 4.21%
- Days to Cover
- 2.69
- 4.41
Stock price statisticsIndustry
- 52-Week High
- $143.90
- –
- 52-Week Low
- $92.77
- –
- 20-Day Moving Average
- $131.77
- –
- 50-Day Moving Average
- $126.30
- –
- 200-Day Moving Average
- $111.90
- –
- Average True Range (14)
- $3.95
- –
- Price Change (1 Week)
- -0.31%
- 0.23%
- Price Change (1 Month)
- 11.3%
- -0.02%
- Price Change (3 Months)
- 13.9%
- 2.13%
- Price Change (6 Months)
- 31.2%
- 17.6%
- Price Change (YTD)
- 32.7%
- 5.22%
- Price Change (1 Year)
- 21.8%
- 3.75%
- Price Change (3 Years)
- 117.8%
- 15.2%
- Price Change (5 Years)
- 120.4%
- -14.6%
- Price Change (10 Years)
- 249.4%
- 184.8%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 985,298
- –
- Relative Volume
- 0.64
- 0.70
- Relative Strength Index (14)
- 65.0
- 46.0
- Volatility (1 Year)
- 30.5%
- 64.2%
- Beta (5 Years)
- 0.68
- 0.76
MarginsIndustry
- Pretax Margin
- 16.6%
- 2.12%
- EBITDA Margin
- 24.2%
- 3.36%
- FCF Margin
- 6.66%
- 2.98%
Returns on capitalIndustry
- Return on Equity (ROE)
- 25.5%
- 4.82%
- Return on Assets (ROA)
- 8.72%
- -3.10%
Financial positionIndustry
- Current Ratio
- 1.19
- 1.41
- Quick Ratio
- 0.91
- 0.99
- Debt / Equity
- 1.01
- 0.68
- Debt / EBITDA
- 1.76
- 2.50
- Debt / FCF
- 6.37
- 4.01
- Net Debt / EBITDA
- 1.68
- 2.13
GrowthIndustry
- Revenue Growth (YoY)
- 9.47%
- 9.63%
- Net Income Growth (YoY)
- 18.8%
- 16.5%
- EPS Growth (YoY)
- 20.2%
- 19.0%
- FCF Growth (YoY)
- -5.87%
- -6.64%
- Revenue Growth (3Y CAGR)
- 10.9%
- 11.3%
- Revenue Growth (5Y CAGR)
- 10.7%
- 12.6%
- EPS Growth (3Y CAGR)
- 27.1%
- 19.8%
- EPS Growth (5Y CAGR)
- 14.2%
- 9.29%
EfficiencyIndustry
- Asset Turnover
- 0.87
- 0.81
- Revenue Per Employee
- $147.76K
- $235.26K
- Profits Per Employee
- $14.79K
- -$5.12K
- Employee Count
- 42,000
- 910
- WACC
- 7.79%
- 8.40%
Income statement (TTM)Industry
- Pretax Income
- $1.03B
- -$575.82K
Balance sheetIndustry
- Net Cash (Debt)
- -$2.53B
- $203.66K
- Net Cash Per Share
- -$25.61
- $0.00
- Equity (Book Value)
- $2.60B
- $235.60M
- Book Value Per Share
- $26.33
- $3.91
- Tangible Book Value
- $967.40M
- $1.59M
- Working Capital
- $167.60M
- $30.06M
Cash flow (TTM)Industry
- Capital Expenditures
- -$799.10M
- -$15.83M
- FCF Per Share
- $4.19
- $0.36
Dividends and yieldsIndustry
- Earnings Yield
- 4.47%
- 0.19%
- FCF Yield
- 2.98%
- 2.55%
- Dividend Yield
- 0.51%
- 0.54%
- Buyback Yield
- 1.78%
- 1.01%
- Shareholder Yield
- 2.29%
- 1.58%
- Dividend Per Share
- $0.72
- $1.30
- Dividend Growth (YoY)
- 12.5%
- 4.55%
- Years of Dividend Growth
- 2
- 4
- Payout Ratio
- 12.1%
- 13.4%
- FCF Payout Ratio
- 18.2%
- 11.9%
Taxes and interestIndustry
- Interest Expense
- $125.60M
- $7.37M
- Income Tax
- $210.30M
- $564.50K
- Effective Tax Rate
- 20.5%
- 24.1%
Scores and fair valueIndustry
- Graham Number
- $60.31
- $21.25
- Graham Upside
- -57.2%
- -49.9%
- Altman Z-Score
- 2.95
- 2.24
- Piotroski F-Score
- 8
- 5
- Lynch Fair Value
- $87.30
- –
- Lynch Upside
- -38.0%
- -23.7%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | EHC | S&P 500 | Difference | EHC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +13.2% | -2.7% | +15.9 pts | ||
| 3 months | +13.0% | -1.7% | +14.8 pts | ||
| Year to date | +33.7% | +11.9% | +21.8 pts | ||
| 1 year | +23.6% | +12.0% | +11.6 pts | ||
| 3 years | +128.9% | +78.2% | +50.8 pts | +31.8% | +21.2% |
| 5 years | +190.8% | +73.2% | +117.6 pts | +23.8% | +11.6% |
| 10 years | +412.7% | +309.6% | +103.0 pts | +17.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M EHC shares were sold short on Oct 30, 2026, up 9.1% from the previous report, or 3.70% of the shares available to trade. At recent volumes it would take 2.7 days to buy them back. Over the last 20 sessions, 50.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,613,983 | +9.1% | 1,343,882 | 2.7 |
| Oct 15, 2026 | 3,312,600 | -5.0% | 941,864 | 3.5 |
| Sep 30, 2026 | 3,488,343 | +16.3% | 981,872 | 3.5 |
| Sep 15, 2026 | 3,000,467 | -7.4% | 728,906 | 4.1 |
| Aug 31, 2026 | 3,240,604 | -1.0% | 873,315 | 3.7 |
| Aug 14, 2026 | 3,274,646 | -10.4% | 1,155,109 | 2.8 |
| Jul 31, 2026 | 3,653,920 | -6.7% | 747,174 | 4.9 |
| Jul 15, 2026 | 3,917,662 | +26.3% | 1,072,732 | 3.6 |
| Jun 30, 2026 | 3,103,037 | -1.4% | 1,428,186 | 2.2 |
| Jun 15, 2026 | 3,145,536 | -6.5% | 823,121 | 3.8 |
| May 29, 2026 | 3,365,633 | -1.3% | 714,363 | 4.7 |
| May 15, 2026 | 3,409,294 | +0.0% | 1,037,100 | 3.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?